NCT04581096

Brief Summary

One of the major problems in suppressing the spreading of an epidemic resides in understanding and monitoring its propagation patterns, and in evaluating how these are modified by enforced policies. The standard solution requires detailed information at the microscopic scales, e.g. how infected people have moved and whom they came in contact with, which is hardly ever available. The researchers propose a novel approach to the study of the propagation of COVID-19, in which a proxy of this information is derived at macroscopic scales. This will be based on two ingredients: the spatiotemporal study in shiny with mathematical models with aggregated or non aggregated data and the reconstruction of functional networks of spreading patterns, and the development of a supporting software.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,646

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2020

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 2, 2020

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

October 7, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 9, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2021

Completed
Last Updated

November 10, 2021

Status Verified

November 1, 2021

Enrollment Period

5 months

First QC Date

October 7, 2020

Last Update Submit

November 3, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • spatiotemporal spread

    spatiotemporal spread of COVID-19 patient in our hospital

    February 1, 2020 to September 30, 2020

Secondary Outcomes (1)

  • classification score

    February 1, 2020 to September 30, 2020

Interventions

just descriptive analysis of clinical data

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with a positive test (PCR or serology) for SARS-CoV-2 in an outpatient regime system

You may qualify if:

  • positive test (PCR or serology) for SARS-CoV-2
  • outpatient follow-up

You may not qualify if:

  • hospitalisation in ward or ICU

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHGUV

Valencia, 46014, Spain

Location

CHGUV

Valencia, Spain

Location

Related Publications (2)

  • Romero Garcia C, Iftimi A, Briz-Redon A, Zanin M, Otero M, Ballester M, de Andres J, Landoni G, de Las Marinas D, Catala Bauset JC, Mandingorra J, Conca J, Correcher J, Ferrer C, Lozano M. Trends in Incidence and Transmission Patterns of COVID-19 in Valencia, Spain. JAMA Netw Open. 2021 Jun 1;4(6):e2113818. doi: 10.1001/jamanetworkopen.2021.13818.

    PMID: 34143191BACKGROUND
  • Briz-Redon A, Iftimi A, Correcher JF, De Andres J, Lozano M, Romero-Garcia C. A comparison of multiple neighborhood matrix specifications for spatio-temporal model fitting: a case study on COVID-19 data. Stoch Environ Res Risk Assess. 2022;36(1):271-282. doi: 10.1007/s00477-021-02077-y. Epub 2021 Aug 18.

    PMID: 34421343BACKGROUND

MeSH Terms

Conditions

COVID-19Spatial NavigationRespiration Disorders

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesSpatial BehaviorBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesia and Critical care consultant

Study Record Dates

First Submitted

October 7, 2020

First Posted

October 9, 2020

Study Start

October 2, 2020

Primary Completion

February 15, 2021

Study Completion

June 15, 2021

Last Updated

November 10, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

there is not ipd sharing planned

Locations